NASDAQ:LHCG LHC Group - LHCG Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding LHC Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $157.18 +0.24 (+0.15%) (As of 01/31/2023 11:39 AM ET) Add Compare Share Share Today's Range$156.93▼$157.9150-Day Range$156.74▼$168.2852-Week Range$115.32▼$169.84Volume183,666 shsAverage Volume403,923 shsMarket Capitalization$4.88 billionP/E Ratio76.67Dividend YieldN/APrice Target$172.50 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media LHC Group MarketRank™ ForecastAnalyst RatingHold2.00 Rating ScoreUpside/Downside9.7% Upside$172.50 Price TargetShort InterestBearish9.29% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.91Based on 5 Articles This WeekInsider TradingN/AProj. Earnings Growth11.57%From $4.32 to $4.82 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.49 out of 5 starsMedical Sector983rd out of 1,055 stocksHome Health Care Services Industry7th out of 9 stocks 1.0 Analyst's Opinion Consensus RatingLHC Group has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 8 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $172.50, LHC Group has a forecasted upside of 9.7% from its current price of $157.30.Amount of Analyst CoverageLHC Group has received no research coverage in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted9.29% of the float of LHC Group has been sold short.Short Interest Ratio / Days to CoverLHC Group has a short interest ratio ("days to cover") of 7.7.Change versus previous monthShort interest in LHC Group has recently increased by 3.77%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldLHC Group does not currently pay a dividend.Dividend GrowthLHC Group does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for LHCG. Previous Next 2.7 News and Social Media Coverage News SentimentLHC Group has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.72 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for LHC Group this week, compared to 1 article on an average week.MarketBeat FollowsOnly 2 people have added LHC Group to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, LHC Group insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.40% of the stock of LHC Group is held by insiders.Percentage Held by Institutions83.47% of the stock of LHC Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for LHC Group are expected to grow by 11.57% in the coming year, from $4.32 to $4.82 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of LHC Group is 76.73, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 128.59.Price to Earnings Ratio vs. SectorThe P/E ratio of LHC Group is 76.73, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 103.53.Price to Earnings Growth RatioLHC Group has a PEG Ratio of 20.99. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioLHC Group has a P/B Ratio of 3.02. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About LHC Group (NASDAQ:LHCG) StockLHC Group, Inc. provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations. The Home Health segment offers a wide range of services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education. The Hospice Services segment offer a wide range of services, including pain and symptom management, emotional and spiritual support, inpatient and respite care, homemaker services, and counseling. The Home & Community-Based Services segment are performed by paraprofessional personnel, and include assistance to the elderly, chronically ill, and disabled patients with activities of daily living. The Facility Based Services segment includes long-term acute care hospitals treats patients with severe medical conditions who require a high-level of care and frequent monitoring by physicians and other clinical persoRead More Receive LHCG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LHC Group and its competitors with MarketBeat's FREE daily newsletter. Email Address LHCG Stock News HeadlinesJanuary 26, 2023 | marketbeat.comMergers and Acquisitions in 2023 Off To A Strong Start (LHCG)Mergers and acquisitions are common, especially across the health sector. Here are some lesser-known buyouts and how they could fare down the road.January 18, 2023 | seekingalpha.comLHCG LHC Group, Inc.January 31, 2023 | PressReach (Ad)Top Lithium StockToday's stock market report features a battery metal lithium stock with great potential.January 17, 2023 | reuters.comLHCG.DF - | Stock Price & Latest News | ReutersNovember 10, 2022 | finance.yahoo.comGDRX or LHCG: Which Is the Better Value Stock Right Now?November 2, 2022 | nasdaq.comLHC Group (LHCG) Q3 Earnings and Revenues Lag EstimatesNovember 2, 2022 | finance.yahoo.comLHC Group announces third quarter 2022 financial resultsOctober 19, 2022 | finance.yahoo.comLHC Group to report third quarter 2022 earnings results on November 2, 2022January 31, 2023 | Investing Trends (Ad)Apple, Amazon, and Walmart are Investing in Solar EnergyThe global market for solar energy is expected to be worth an astronomical $1 trillion by the end of 2028, with increasing adoption of solar by commercial, non-profit, and public entities. Even Fortune 500 companies such as Apple, Amazon, and Walmart are investing in solar to help save money over the long term. So it's little wonder solar is also becoming one of the fastest growing sectors in the U.S. stock market.October 18, 2022 | finance.yahoo.comLHC Group, Inc. (LHCG)August 11, 2022 | finance.yahoo.comThe 10 Stocks That Account for 90.88% of Varenne Capital’s 13F PortfolioAugust 3, 2022 | finance.yahoo.comLHC Group (LHCG) Lags Q2 Earnings and Revenue EstimatesAugust 3, 2022 | finance.yahoo.comLHC Group announces second quarter 2022 financial resultsJuly 15, 2022 | morningstar.comLHC Group Inc - Stock NewsJuly 13, 2022 | finance.yahoo.comLHC Group to report second quarter 2022 earnings results on August 3, 2022June 15, 2022 | nasdaq.comLHC Group is Now Oversold (LHCG)May 19, 2022 | msn.comLHC Group's Return On Capital Employed OverviewMay 13, 2022 | morningstar.comSHAREHOLDER ALERT: Weiss Law Reminds LHCG, NLSN, GDNSF, and MSP Shareholders About Its Ongoing InvestigationsMay 5, 2022 | apnews.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CNR, Y, VEC, LHCGMay 5, 2022 | finance.yahoo.comLHC Group (LHCG) Q1 Earnings Surpass EstimatesMay 4, 2022 | investing.comLHC Group Tops Q1 EPS by 4cMay 4, 2022 | finance.yahoo.comLHC Group announces first quarter 2022 financial resultsApril 25, 2022 | finance.yahoo.comLHC Group to report first quarter 2022 earnings results on May 4, 2022April 19, 2022 | apnews.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates NLSN, TVTY, RNDB, LHCGApril 18, 2022 | markets.businessinsider.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates NLSN, LHCG, RNDB, SWMApril 13, 2022 | baystreet.caSHAREHOLDER NOTICE: Halper Sadeh LLP Investigates LHCG, NLSN, MN, SAVEApril 11, 2022 | apnews.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates LHCG, NLSN, TVTY, TUFNSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive LHCG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LHC Group and its competitors with MarketBeat's FREE daily newsletter. Email Address LHCG Company Calendar Last Earnings11/02/2022Today1/31/2023Next Earnings (Estimated)2/22/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Home health care services Sub-IndustryHealth Care Services SectorMedical Current SymbolNASDAQ:LHCG CUSIP50187A10 CIK1303313 Webwww.lhcgroup.com Phone(337) 233-1307Fax337-235-8037Employees30,000Year Founded1994Price Target and Rating Average Stock Price Forecast$172.50 High Stock Price Forecast$185.00 Low Stock Price Forecast$170.00 Forecasted Upside/Downside+9.7%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)$2.05 Trailing P/E Ratio76.67 Forward P/E Ratio36.38 P/E Growth20.99Net Income$115.73 million Net Margins2.73% Pretax Margin4.56% Return on Equity8.13% Return on Assets4.63% Debt Debt-to-Equity Ratio0.44 Current Ratio1.45 Quick Ratio1.45 Sales & Book Value Annual Sales$2.22 billion Price / Sales2.20 Cash Flow$7.53 per share Price / Cash Flow20.86 Book Value$52.17 per share Price / Book3.01Miscellaneous Outstanding Shares31,030,000Free Float29,668,000Market Cap$4.88 billion OptionableOptionable Beta0.44 Social Links Key ExecutivesKeith G. MyersChairman & Chief Executive OfficerJoshua L. ProffittPresident & Chief Operating OfficerDale G. MackelChief Financial Officer, Treasurer & Executive VPAngie M. BegnaudChief Clinical Officer & Executive Vice PresidentBenjamin DogaChief Medical OfficerKey CompetitorsAmedisysNASDAQ:AMEDChemedNYSE:CHEOption Care HealthNASDAQ:OPCHSignify HealthNYSE:SGFYAdaptHealthNASDAQ:AHCOView All CompetitorsInsiders & InstitutionsVersor Investments LPSold 140,630 shares on 1/30/2023Ownership: 0.952%New York State Common Retirement FundBought 700 shares on 1/30/2023Ownership: 0.089%State of Michigan Retirement SystemBought 100 shares on 1/27/2023Ownership: 0.026%Campbell Newman Asset Management Inc.Sold 71 shares on 1/26/2023Ownership: 0.040%Inspire Investing LLCBought 243 shares on 1/26/2023Ownership: 0.005%View All Institutional Transactions LHCG Stock - Frequently Asked Questions Should I buy or sell LHC Group stock right now? 8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for LHC Group in the last year. There are currently 8 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" LHCG shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LHCG, but not buy additional shares or sell existing shares. View LHCG analyst ratings or view top-rated stocks. What is LHC Group's stock price forecast for 2023? 8 Wall Street research analysts have issued 12 month target prices for LHC Group's shares. Their LHCG share price forecasts range from $170.00 to $185.00. On average, they anticipate the company's share price to reach $172.50 in the next year. This suggests a possible upside of 9.9% from the stock's current price. View analysts price targets for LHCG or view top-rated stocks among Wall Street analysts. How have LHCG shares performed in 2023? LHC Group's stock was trading at $161.69 at the beginning of the year. Since then, LHCG stock has decreased by 2.9% and is now trading at $156.94. View the best growth stocks for 2023 here. When is LHC Group's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 22nd 2023. View our LHCG earnings forecast. How were LHC Group's earnings last quarter? LHC Group, Inc. (NASDAQ:LHCG) posted its earnings results on Wednesday, November, 2nd. The health services provider reported $1.06 earnings per share for the quarter, missing analysts' consensus estimates of $1.37 by $0.31. The health services provider earned $576.91 million during the quarter, compared to analyst estimates of $616.65 million. LHC Group had a net margin of 2.73% and a trailing twelve-month return on equity of 8.13%. What is Keith G. Myers' approval rating as LHC Group's CEO? 524 employees have rated LHC Group Chief Executive Officer Keith G. Myers on Glassdoor.com. Keith G. Myers has an approval rating of 87% among the company's employees. What other stocks do shareholders of LHC Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other LHC Group investors own include Verizon Communications (VZ), NVIDIA (NVDA), Home Depot (HD), Cisco Systems (CSCO), Visa (V), CVS Health (CVS), Johnson & Johnson (JNJ), Alibaba Group (BABA), Chevron (CVX) and Intel (INTC). What is LHC Group's stock symbol? LHC Group trades on the NASDAQ under the ticker symbol "LHCG." Who are LHC Group's major shareholders? LHC Group's stock is owned by many different retail and institutional investors. Top institutional investors include Versor Investments LP (0.95%), Syquant Capital Sas (0.39%), Calamos Advisors LLC (0.32%), Ziegler Capital Management LLC (0.15%), New York State Common Retirement Fund (0.09%) and Bridge City Capital LLC (0.05%). Insiders that own company stock include Nicholas Gachassin III, Ronald T Nixon and W Earl Reed III. View institutional ownership trends. How do I buy shares of LHC Group? Shares of LHCG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is LHC Group's stock price today? One share of LHCG stock can currently be purchased for approximately $156.94. How much money does LHC Group make? LHC Group (NASDAQ:LHCG) has a market capitalization of $4.87 billion and generates $2.22 billion in revenue each year. The health services provider earns $115.73 million in net income (profit) each year or $2.05 on an earnings per share basis. How many employees does LHC Group have? The company employs 30,000 workers across the globe. How can I contact LHC Group? LHC Group's mailing address is 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508. The official website for the company is www.lhcgroup.com. The health services provider can be reached via phone at (337) 233-1307, via email at eric.elliott@lhcgroup.com, or via fax at 337-235-8037. This page (NASDAQ:LHCG) was last updated on 1/31/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.